Finanzen von SRx Global Inc (SRXH)SRXHSRx Global Inc

SRx Global Inc (SRXH) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Health Solutions, accounting for 76.6% of total sales, equivalent to $8.77M. Another important revenue stream is Consumer Products. Understanding this composition is critical for investors evaluating how SRXH navigates market cycles within the IT Services & Consulting industry.

Evaluating the bottom line, SRx Global Inc maintains a gross margin of 26.65%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -94.37%, while the net margin is -122.05%. These profitability ratios, combined with a Return on Equity (ROE) of 4.06%, provide a clear picture of how effectively SRXH converts its operational activities into shareholder value.

In the context of the broader market, SRXH competes directly with industry leaders such as LPSN and ONMD. With a market capitalization of $38.91M, it holds a significant position in the sector. When comparing efficiency, SRXH's gross margin of 26.65% stands against LPSN's 60.05% and ONMD's -193.49%. Such benchmarking helps identify whether SRx Global Inc is trading at a premium or discount relative to its financial performance.

The company has shown fluctuating revenue, with total revenue for 2026/Q2 at 3,439,000 USD, but it has also faced significant net income losses, with a net income of -6,381,000 USD in the same quarter. The gross margin has been inconsistent, with a recent gross margin of 37.07%.